Mode
Text Size
Log in / Sign up

fremanezumab

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of fremanezumab

9 trials tracked of fremanezumab: 8 in phase 3 or 4 and 6 with published results. The most-cited published study has 177 citations.

9Trials tracked
8Phase 3 & 4
0Recruiting
6With published results
Phase distribution
Phase 4 1 Phase 3 7 Phase 2 1
  1. Phase 3 Efficacy and Safety of Subcutaneous Administration of Fremanezumab (TEV-48125) for the Preventive Treatment of Migraine Completed · 177 cited
  2. Phase 3 Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine Completed · 129 cited
  3. Phase 3 Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine Completed · 31 cited
  4. Phase 3 An Efficacy and Safety Study of Fremanezumab in Adults With Migraine Completed · 30 cited
  5. Phase 4 A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive Disorder Completed · 19 cited
  6. Phase 3 A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age Completed · 11 cited
Show 3 more trials
  1. Phase 3 A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With Migraine Completed
  2. Phase 3 A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age Completed
  3. Phase 2 A Study to Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH) Completed

Showing the 9 most-cited and recently-updated of 9 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.